April 15, 2015
View Full PaperProfile of the Immune and Inflammatory Response in Individuals With Prediabetes and Type 2 Diabetes
Key Points
Key points are not available for this paper at this time.
Abstract
The inflammatory and immune biomarker profile varies with the development and progression of type 2 diabetes. Markers of inflammation and immunity enable differentiation between the early preclinical and clinical phases of the disease, disease complications, and progression.
Cite This Study
Großmann et al. (Wed,) studied this question.